Back to top
more

RadNet (RDNT)

(Delayed Data from NSDQ)

$55.46 USD

55.46
782,207

-0.31 (-0.56%)

Updated Aug 5, 2025 04:00 PM ET

After-Market: $55.46 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 246)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

RadNet (RDNT) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of 200% and 1.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Chemed (CHE) Q2 Earnings Surpass Estimates

by Zacks Equity Research

Chemed (CHE) delivered earnings and revenue surprises of 1.26% and 1.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

3 Stocks to Watch From a Buoyant Outpatient Home Health Industry

by Trina Mukherjee

Despite the COVID-19 pandemic-induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.

Zacks Equity Research

RadNet (RDNT) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of -650% and 1.84%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

RadNet (RDNT) Q4 Earnings and Revenues Miss Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of -31.58% and 4.26%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Oak Street Health, Inc. (OSH) Reports Q4 Loss, Tops Revenue Estimates

by Zacks Equity Research

Oak Street Health, Inc. (OSH) delivered earnings and revenue surprises of -5.08% and 2.23%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 23.53% and 1.11%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Amedisys (AMED) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Amedisys (AMED) delivered earnings and revenue surprises of 0.86% and 0.73%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zacks Industry Outlook Highlights DaVita, RadNet and U.S. Physical Therapy

by Zacks Equity Research

DaVita, RadNet and U.S. Physical Therapy are included in this blog.

Trina Mukherjee headshot

3 Stocks to Bank on the Buoyant Outpatient Home Health Industry

by Trina Mukherjee

Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DVA, RDNT and USPH are well-poised to gain from the prospects.

Zacks Equity Research

RadNet (RDNT) Q3 Earnings Top Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of 5.00% and -2.79%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

RadNet (RDNT) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

RadNet (RDNT) closed at $31.96 in the latest trading session, marking a -0.87% move from the prior day.

Zacks Equity Research

RadNet (RDNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics

by Zacks Equity Research

Zacks Industry Outlook Highlights: Encompass Health, RadNet, U.S. Physical Therapy and Quest Diagnostics

Trina Mukherjee headshot

3 Top Stocks From the Buoyant Outpatient Home Health Industry

by Trina Mukherjee

Despite the COVID-19 pandemic induced challenges, rising dependence on telehealth and AI's dominant role are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. EHC, RDNT and USPH are well-poised to gain from the prospects.

Zacks Equity Research

New Strong Buy Stocks for September 20th

by Zacks Equity Research

RDNT, ACH, FNF, MG, and TPR have been added to the Zacks Rank #1 (Strong Buy) List on September 20, 2021.

Zacks Equity Research

New Strong Buy Stocks for September 14th

by Zacks Equity Research

CPRI, MAN, RDNT, HSII, and OLN have been added to the Zacks Rank #1 (Strong Buy) List on September 14, 2021.

Zacks Equity Research

New Strong Buy Stocks for September 1st

by Zacks Equity Research

BBY, CNHI, RDNT, SALM, and TOL have been added to the Zacks Rank #1 (Strong Buy) List on September 1, 2021.

Zacks Equity Research

New Strong Buy Stocks for August 30th

by Zacks Equity Research

DSKE, HNGR, GPS, SCSC, and RDNT have been added to the Zacks Rank #1 (Strong Buy) List on August 30, 2021

Zacks Equity Research

Zacks.com featured highlights include: NBT Bancorp, Bio-Rad Laboratories, RadNet, Arbor Realty Trust and Cathay General Bancorp

by Zacks Equity Research

Zacks.com featured highlights include: NBT Bancorp, Bio-Rad Laboratories, RadNet, Arbor Realty Trust and Cathay General Bancorp

Shrabana Mukherjee headshot

New Analyst Coverage Puts Spotlight on These 5 Stocks

by Shrabana Mukherjee

Increased analyst coverage over the past few weeks might lead to solid price appreciation for stocks like NBTB, BIO, RDNT, ABR and CATY.

Zacks Equity Research

New Strong Buy Stocks for August 19th

by Zacks Equity Research

AOSL, CCS, GMS, RDNT, and SALM have been added to the Zacks Rank #1 (Strong Buy) List on August 19, 2021.

Zacks Equity Research

RadNet (RDNT) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

RadNet (RDNT) delivered earnings and revenue surprises of 92.86% and 2.18%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

RadNet (RDNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research

RadNet (RDNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

RadNet (RDNT) Hits Fresh High: Is There Still Room to Run?

by Zacks Equity Research

RadNet (RDNT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.